Rare Disease Treatments
Pharmaceutical and biotech companies developing orphan drugs and therapies for rare diseases affecting small patient populations
Theme performance
Symbols
LLYLilly(Eli) & CoMarket Cap: $1.1T
ABBVAbbvie IncMarket Cap: $468.2B
NOVNNovartis AGMarket Cap: $303.1B
AMGNAMGEN Inc.Market Cap: $237.5B
NVONovo NordiskMarket Cap: $208.7B
VRTXVertex Pharmaceuticals, Inc.Market Cap: $138.9B
BRMBristol-Myers Squibb Co.Market Cap: $136.9B
BMYBristol-Myers Squibb Co.Market Cap: $136.9B
REGNRegeneron Pharmaceuticals, Inc.Market Cap: $85.9B
ARGXArgen X SEMarket Cap: $64.3B
MRNAModerna IncMarket Cap: $57.9B
SNYSanofiMarket Cap: $55.9B
EDGGold Fields LtdMarket Cap: $37.1B
BIIBBiogen IncMarket Cap: $32B
ALNYAlnylam Pharmaceuticals IncMarket Cap: $31.6B
TAKTakeda Pharmaceutical CoMarket Cap: $31.3B
INSMInsmed IncMarket Cap: $27.5B
ROIVRoivant Sciences LtdMarket Cap: $26.2B
INCYIncyte Corp.Market Cap: $25.9B
UTHRUnited Therapeutics CorpMarket Cap: $22B